rasagiline

Known as: (R)-Indan-1-yl-prop-2-ynyl-amine, rasagiline [Chemical/Ingredient], RAS 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1974-2017
020406019742017

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2009
Highly Cited
2009
BACKGROUND A therapy that slows disease progression is the major unmet need in Parkinson's disease. METHODS In this double… (More)
  • figure 1
  • figure 2
  • table 1
  • table 2
  • figure 3
Is this relevant?
Highly Cited
2005
Highly Cited
2005
BACKGROUND Rasagiline mesylate is a novel drug for Parkinson's disease with selective, irreversible monoamine oxidase B (MAO-B… (More)
Is this relevant?
Highly Cited
2005
Highly Cited
2005
  • Archives of neurology
  • 2005
BACKGROUND Rasagiline (n-propargyl-1[R]-aminoindan) mesylate is a novel irreversible selective monoamine oxidase type B inhibitor… (More)
Is this relevant?
Highly Cited
2004
Highly Cited
2004
  • Archives of neurology
  • 2004
BACKGROUND Treatment with rasagiline mesylate, an irreversible monoamine oxidase type B inhibitor, improves symptoms of early… (More)
Is this relevant?
2004
2004
Sprague-Dawley rats received a unilateral injection of 6-hydroxydopamine (6-OHDA) into the striatum and were treated daily for 6… (More)
Is this relevant?
Highly Cited
2002
Highly Cited
2002
The role of mitochondrial permeability transition (PT) in apoptosis induced by an endogenous neurotoxin, N-methyl(R)salsolinol… (More)
Is this relevant?
Highly Cited
2001
Highly Cited
2001
1. Rasagiline [N-propargyl-1R(+)-aminoindan], was examined for its monoamine oxidase (MAO) A and B inhibitor activities in rats… (More)
Is this relevant?
2001
2001
The antiapoptotic and neuroprotective activity of irreversible monoamine oxidase (MAO) B inhibitor, rasagiline [R(+)-N-propargyl… (More)
Is this relevant?
1996
1996
Rasagiline [R(+)-N-propargyl-1-aminoindane] is a selective irreversible inhibitor of MAO-B which is not metabolised to… (More)
Is this relevant?
Highly Cited
1994
Highly Cited
1994
Insulin stimulation drives the formation of a complex between tyrosine-phosphorylated insulin receptor substrate 1 (IRS-1) and 1… (More)
Is this relevant?